Perioperative Pembrolizumab for Early-Stage Non–Small-Cell Lung CancerHeather A. Wakelee, Jonathan Spicer, Olivier Bylicki et al.|New England Journal of Medicine|2023Cited by 1k
Perioperative Toripalimab Plus Chemotherapy for Patients With Resectable Non–Small Cell Lung CancerShun Lü, Xiaosheng Hang, Wei Zhang et al.|JAMA|2024Cited by 359
Neoadjuvant pembrolizumab plus chemotherapy followed by adjuvant pembrolizumab compared with neoadjuvant chemotherapy alone in patients with early-stage non-small-cell lung cancer (KEYNOTE-671): a randomised, double-blind, placebo-controlled, phase 3 trialJonathan Spicer, Marina Chiara Garassino, Heather A. Wakelee et al.|The Lancet|2024Cited by 233
Expert consensus on multidisciplinary therapy of colorectal cancer with lung metastases (2019 edition)Jian Li, Feng Lin, Ying Yuan et al.|Journal of Hematology & Oncology|2019Cited by 124
Adebrelimab (SHR-1316) in Combination With Chemotherapy as Perioperative Treatment in Patients With Resectable Stage II to III NSCLCs: An Open-Label, Multicenter, Phase 1b TrialWanpu Yan, Yi‐Long Wu, Wen‐Zhao Zhong et al.|Journal of Thoracic Oncology|2022Cited by 34